Petros Pharmaceuticals strengthens partnership with big data provider
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 06 2025
0mins
Should l Buy ?
AI Platform Enhancements: Petros Pharmaceuticals has improved its AI platform to enhance processing, fraud detection, and user experience, incorporating features like Deep Fake detection and advanced facial recognition.
SaaS Integration: The upgraded AI platform will be a crucial part of the company's new SaaS-based technology aimed at facilitating over-the-counter access to established prescription drugs.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
